Patent · US Active

Methods of treatment with arginine deiminase

US10525142B2 · kind B2 · utility

0Cited by
6References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 12, 2017
Grant dateJan 7, 2020
Priority date
Expiry dateJul 12, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates generally to methods of treating cancer with arginine deiminase, and in particular pegylated arginine deiminase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.